Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OraSure Plans To File Over-The-Counter HIV Test Application By Year End

This article was originally published in The Tan Sheet

Executive Summary

OraSure Technologies says it expects this year to complete a pre-market application for its OraQuick Advance Rapid HIV-1 and -2 over-the-counter saliva test. The product would be the first HIV diagnostic intended for use at home and providing results directly to the user.
Advertisement

Related Content

Advisory Panel Endorses OraSure In-Home HIV Test
Advisory Panel Endorses OraSure In-Home HIV Test
The Future Of OTCs: Self-Selection Meets Diagnostics, Genetic Personalization
The Future Of OTCs: Self-Selection Meets Diagnostics, Genetic Personalization
Chembio HIV Tests Could Present OTC Competition For OraSure
Advisory Panel Shows Support for OTC HIV Test, Highlights Community Need

Topics

Advertisement
UsernamePublicRestriction

Register

PS105243

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel